FDA Fireside Chat
October 23, 2026
Grand Ballroom
Type: Keynote
Join us for a moderated discussion between BIO CEO John Crowley and Dr. Mike Davis, Director of the Center for Drug Evaluation and Research (CDER) and Karim Mikhail, Director of the Center for Biologics Evaluation and Research (CBER) of the U.S. Food and Drug Administration (FDA).
Topics will include center priorities, patient engagement, and FDA in the next one, five, and twenty years.
Moderator
Speakers
Center Director, Center for Drug Evaluation and Research (CDER)
U.S. Food and Drug Administration (FDA)
Director, Center for Biologics Evaluation and Research (CBER)
U.S. Food and Drug Administration (FDA)